<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04563806</url>
  </required_header>
  <id_info>
    <org_study_id>2017-0663</org_study_id>
    <secondary_id>NCI-2020-03700</secondary_id>
    <secondary_id>2017-0663</secondary_id>
    <nct_id>NCT04563806</nct_id>
  </id_info>
  <brief_title>Safety of MRI Compatible Hardware for MRI-based Image Guidance During Spine Surgery</brief_title>
  <official_title>A Pilot Study to Evaluate the Safety of MRI Compatible Hardware for Intraoperative MRI-Based Image Guidance for Spinal Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>M.D. Anderson Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>M.D. Anderson Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial investigates the safety and accuracy of using 2 pieces of hardware (a clamp and a&#xD;
      needle) that are able to be used with magnetic resonance imaging (MRI) during spinal surgery.&#xD;
      During a standard spinal surgery, a computed tomography (CT) scan is used to help plan the&#xD;
      placement of surgical instruments used during the procedure or for needle biopsies. Then, the&#xD;
      patient is moved to the MRI. For this study, the patient is able to stay in place as the&#xD;
      hardware used in this study is able to work with the MRI. Using MRI compatible hardware may&#xD;
      allow for an extra degree of safety and facilitate better surgical workflow.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVE:&#xD;
&#xD;
      I. To document the safety of utilizing MRI compatible hardware for intraoperative MRI-based&#xD;
      image guidance to perform percutaneous spinal procedures.&#xD;
&#xD;
      SECONDARY OBJECTIVE:&#xD;
&#xD;
      I. To determine the accuracy of the MRI-based image guidance.&#xD;
&#xD;
      OUTLINE:&#xD;
&#xD;
      Patients undergo standard of care spine surgery with MRI-based image guidance.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 18, 2019</start_date>
  <completion_date type="Anticipated">April 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2022</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of intraoperative adverse events</measure>
    <time_frame>During surgery</time_frame>
    <description>Safety will be assessed as a dichotomous variable. Frequencies and descriptive statistics of the outcomes under study will be performed. 95% confidence intervals will be computed. Other ad-hoc analyses may be performed as well.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Thoracic Spine Neoplasm</condition>
  <arm_group>
    <arm_group_label>Device feasibility (MRI-guided surgery)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergo standard of care spine surgery with MRI-based image guidance.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Magnetic Resonance Imaging</intervention_name>
    <description>Undergo MRI-guided surgery</description>
    <arm_group_label>Device feasibility (MRI-guided surgery)</arm_group_label>
    <other_name>Magnetic Resonance Imaging Scan</other_name>
    <other_name>Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance</other_name>
    <other_name>MR Imaging</other_name>
    <other_name>MRI</other_name>
    <other_name>MRI Scan</other_name>
    <other_name>NMR Imaging</other_name>
    <other_name>NMRI</other_name>
    <other_name>Nuclear Magnetic Resonance Imaging</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Therapeutic Conventional Surgery</intervention_name>
    <description>Undergo spinal surgery</description>
    <arm_group_label>Device feasibility (MRI-guided surgery)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing percutaneous spinal procedures requiring image guidance at MD&#xD;
             Anderson&#xD;
&#xD;
          -  Age &gt; 18 years old. (The indication for this technique is controversial in skeletally&#xD;
             immature patients.)&#xD;
&#xD;
          -  All diagnoses are eligible&#xD;
&#xD;
          -  Vertebral body site to be treated located from T2 to T12&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Requires open spinal procedure or a percutaneous procedure without the use of image&#xD;
             guidance&#xD;
&#xD;
          -  Unable to tolerate general anesthesia and prone position&#xD;
&#xD;
          -  Unable to undergo MRI scan of the spine&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claudio E Tatsui</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.D. Anderson Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Claudio E Tatsui</last_name>
    <phone>713-792-2400</phone>
    <email>cetatsui@mdanderson.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>M D Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudio E. Tatsui</last_name>
      <phone>713-792-2400</phone>
      <email>cetatui@mdanderson.org</email>
    </contact>
    <investigator>
      <last_name>Claudio E. Tatsui</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mdanderson.org</url>
    <description>M D Anderson Cancer Center</description>
  </link>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>June 10, 2020</study_first_submitted>
  <study_first_submitted_qc>September 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 24, 2020</study_first_posted>
  <last_update_submitted>November 10, 2021</last_update_submitted>
  <last_update_submitted_qc>November 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

